Do We Get Samples of the Report?

Yes, you will receive a sample copy of the market research report from the sales team when you put a query to us. The sample report is free and offers a brief view of the report and information on data available before you purchase the full-fledged report. Also, we will provide a demo sample for any oncoming study.

How to Buy a Market Report?

Select the report you wish to purchase and proceed to buy it by making an online payment. We use a secured gateway for payment transfers and do not share your financial information with any unconcerned third party.

In Which Format Will I Get the Report?

The report will be delivered in spreadsheet and PDF format. In some cases, PPT formats could be available as well.

In How Much Time I will Get the Report After Purchase?

After confirmation of the payment, you will receive the electronic format of the report at your registered email address in (mention the timeline for the delivery). If you buy a report over a holiday or weekend, we will process the request the next working day.

How Can I Get the Report Customized?

Market studies and reports already contain important data and are ready for distribution to the purchaser. However, if there is any particular query, addition, or customization you require, then contact us on our email id or phone. We will look to accommodate your request and see what can be done at the earliest. The research team will design the report accordingly and discuss the solutions beforehand with you.

How Much Will It Cost to Get a Report Customized?

The price of the customized report will be conveyed to you by our team after we agree on the deliverable. A delivery timeline will be set so that you get the report within the expected date. Any requests for customizations after selling the report will be handled by a separate department and the prices for the same mentioned upfront.

Can I Buy Only a Particular Segment of the Study?

While usually such a request is not accommodated as any market research report is wholesome and the cost of the report is for overall contents, in special cases, we may be able to sell select segments of the report based on your requirements.

Is There Any Available Discount?

Our team will love to support academicians, start-ups, students, and others with consulting and research. Thus, our pricing plan is based on keeping these interests in mind and is already affordable. However, we may have discounts available for particular customer types and reports. So, contact us for more information.

Which Services Are Complimentary Before Purchasing the Report?

We have consumer-centric reports and offer several facilities before selling. You will get a free review and sample report, talk to our customer care team for any additions to be done and meet special requirements, and interact with our analysts for deeper understanding.

Will I Receive a Bill or Invoice for the Report Purchased?

Yes, you will get an invoice for the purchase you made. The invoice will be sent to you electronically on your registered email id.

What If I am Unable to Find the Report in the Catalog?

We have a vast database of market reports and studies and there are a few which may not have been uploaded yet. If you are unable to find the one you want, then get in touch with our sales team by phone or email and we will connect with you for assistance.

How Often Are the Existing Studies Updated?

Not every study is the same. Thus, the update for reports will depend on the ongoing research and changes if any to be incorporated in the document or not.

What If the Report Does Not Contain the Information I Want?

The market research reports are constructed keeping in mind the industry trends, nature of the study, and required inputs. But if you want something more than what is stated in the report, we can help you out with further research if possible. Contact us right away, and we will do the needful to aid you.

Is the Payment Refundable?

Once the payment is done, it is non-refundable because as per the standard policy, the utility of the reports is based on knowledge sharing, and thus, a refund is not possible to make after we have issued you obtain the study. To avoid the hassle, we have a detailed view of the report and its ideas through a sample report.

What If the Payment Fails?

If the payment fails then be assured that you shall receive the money back to the source payment mode from the payment gateway. Aarkstore is not responsible for any loss of payment in the process.

Can I Avail the Report of a Particular Country/Region?

Yes, we can provide a report or segment related to a particular region or geography if we have that feature available for the document.

Do You Offer Support After Purchase?

Yes, we are here to solve any queries you may have for the report from our analyst till a given timeframe. To understand more about this, get in touch with us.

Akorn Inc (AKRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

DESCRIPTION

TABLE OF CONTENTS

RELATED REPORTS

SAMPLE REQUEST

REVIEWS

DESCRIPTION

Summary

Akorn Inc (Akorn) is a pharmaceutical company which carries out the development, manufacturing and commercialization of generic and branded prescription pharmaceuticals and branded and over-the-counter consumer health products and animal health pharmaceuticals. The company offers its products in various sterile and non-sterile dosage forms including oral liquids, otics, ophthalmics, injectables, topicals, inhalants, and nasal sprays. It also offers contract manufacturing services. Akorn offers its products and services to physicians, surgery centers, clinics, optometrists, hospitals, long-term care, wholesalers, retail pharmacies, group purchasing organizations and other pharmaceutical companies. It operates manufacturing facilities in India and the US. The company has presence in the US, Canada, Mauritius, Luxembourg, Switzerland and India. Akorn is headquartered in Lake Forest, Illinois, the US.

Akorn Inc (AKRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

TABLE OF CONTENTS

2
List of Tables 4
List of Figures 5
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Akorn Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Akorn Inc, Medical Devices Deals, 2011 to YTD 2017 11
Akorn Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Akorn Inc, Pharmaceuticals & Healthcare, Deal Details 15
Asset Purchase 15
Akorn to Acquire Xopenex Inhalation Solution from Sunovion Pharma for USD45 Million 15
Oak Pharma Acquires Tafluprost Business from Merck 16
Akorn Acquires Betimol, Opthalmic Drug, From Santen 16
Hi-Tech Pharmacal Acquires Rights To Cormax From Watson Labs 17
Hi-Tech Pharmacal Acquires Homeopathic Nasal Spray Products From Dynova Labs 18
Akorn Completes Acquisition Of Manufacturing Assets Of Kilitch Drugs 19
Oak Pharma Acquires Three Hospital-Based Injectables From H. Lundbeck 20
Hi-Tech Pharmacal Acquires Rights To Branded Products From Atley Pharma 21
Hi-Tech Pharmacal Acquires Nystatin Oral Suspension ANDA From Bausch & Lomb 22
Partnerships 23
Knight Therapeutics Enters into Distribution Agreement with Akorn 23
Hi-Tech Pharmacal Enters Into Co-Marketing Agreement With Mallinckrodt For TussiCaps 23
Elite Pharma Enters Into Co-Development Agreement With Hi-Tech Pharmacal 24
Licensing Agreements 25
Akorn Enters Into Licensing Agreement With Aciex Therapeutics 25
Shenzhen Hybio Pharma Enters into Licensing Agreement with Akorn 26
Santen Pharma Enters into Licensing Agreement with Oak Pharma 27
InSite Vision Amends Licensing Agreement With Inspire Pharma For AzaSite 27
Hi-Tech Pharmacal Enters Into Licensing Agreement With Septodont For Lidocaine 5% Ointment 28
Hi-Tech Pharmacal Enters Into Licensing Agreement With Glycobiosciences For Hylase Wound Gel 29
Hi-Tech Pharmacal Enters Into Licensing Agreement With KVK-Tech For Lodrane 29
Inspire Pharma Amends Licensing Agreement With Yamasa 30
Debt Offering 31
Akorn Completes Private Placement Of Convertible Senior Notes Due 2016 For US$120 Million 31
Asset Transactions 32
Actavis Acquires Four Generic Products From Akorn And Hi-Tech Pharmacal 32
InSite Vision Regains North American Development Rights To AzaSite Xtra From Inspire Pharma 33
Acquisition 34
Fresenius to Acquire Akorn 34
Akorn Acquires VersaPharm from Tailwind Capital Partners for USD433 Million 36
Valeant Pharma Acquires ECR Pharma from Akorn for USD41 Million 38
Akorn Completes Acquisition Of Hi-Tech Pharmacal For US$640 Million 39
Akorn Acquires Inspire Pharma From Merck For US$53 Million 40
Serum Institute Plans To Sell Its Stake In Akorn 42
Akorn To Acquire Minority Stake In Aciex Therapeutics 43
Merck Completes Acquisition Of Inspire Pharma 44
Metrics Acquires Midlothian Labs From Hi-Tech Pharmacal 46
Akorn Acquires Advanced Vision Research For US$26 Million 47
Akorn Inc - Key Competitors 48
Key Employees 49
Locations And Subsidiaries 50
Head Office 50
Other Locations & Subsidiaries 50
Recent Developments 51
Financial Announcements 51
Mar 01, 2017: Akorn Provides Fourth Quarter and Full Year 2016 Results and Outlines Full Year 2017 Guidance 51
Nov 03, 2016: Akorn Provides Third Quarter 2016 Results 53
Aug 04, 2016: Akorn Provides Second Quarter 2016 Results 54
May 16, 2016: Akorn Provides First Quarter 2016 Results 55
May 10, 2016: Akorn Completes 2014 Financial Statement Restatement and Reports Audited 2015 and Restated 2014 Results 57
Mar 22, 2016: Akorn Provides Preliminary Unaudited Full Year 2015 Financial Results and Issues 2016 Financial Guidance 59
Jan 14, 2016: Akorn Provides Material Updates 61
Corporate Communications 62
Mar 07, 2016: Akorn Receives Expected Additional Delinquency Notice From Nasdaq 62
Jan 21, 2016: Akorn Appoints Greg Lawless as Chief Human Resources Officer 63
Legal and Regulatory 64
Dec 12, 2016: Akorn Announces Completion of FDA Re-inspection of Decatur Facility 64
Appendix 65
Methodology 65
About GlobalData 65
Contact Us 65
Disclaimer 65

List Of Tables

Akorn Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Akorn Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Akorn Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Akorn Inc, Medical Devices Deals, 2011 to YTD 2017 11
Akorn Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Akorn to Acquire Xopenex Inhalation Solution from Sunovion Pharma for USD45 Million 15
Oak Pharma Acquires Tafluprost Business from Merck 16
Akorn Acquires Betimol, Opthalmic Drug, From Santen 16
Hi-Tech Pharmacal Acquires Rights To Cormax From Watson Labs 17
Hi-Tech Pharmacal Acquires Homeopathic Nasal Spray Products From Dynova Labs 18
Akorn Completes Acquisition Of Manufacturing Assets Of Kilitch Drugs 19
Oak Pharma Acquires Three Hospital-Based Injectables From H. Lundbeck 20
Hi-Tech Pharmacal Acquires Rights To Branded Products From Atley Pharma 21
Hi-Tech Pharmacal Acquires Nystatin Oral Suspension ANDA From Bausch & Lomb 22
Knight Therapeutics Enters into Distribution Agreement with Akorn 23
Hi-Tech Pharmacal Enters Into Co-Marketing Agreement With Mallinckrodt For TussiCaps 23
Elite Pharma Enters Into Co-Development Agreement With Hi-Tech Pharmacal 24
Akorn Enters Into Licensing Agreement With Aciex Therapeutics 25
Shenzhen Hybio Pharma Enters into Licensing Agreement with Akorn 26
Santen Pharma Enters into Licensing Agreement with Oak Pharma 27
InSite Vision Amends Licensing Agreement With Inspire Pharma For AzaSite 27
Hi-Tech Pharmacal Enters Into Licensing Agreement With Septodont For Lidocaine 5% Ointment 28
Hi-Tech Pharmacal Enters Into Licensing Agreement With Glycobiosciences For Hylase Wound Gel 29
Hi-Tech Pharmacal Enters Into Licensing Agreement With KVK-Tech For Lodrane 29
Inspire Pharma Amends Licensing Agreement With Yamasa 30
Akorn Completes Private Placement Of Convertible Senior Notes Due 2016 For US$120 Million 31
Actavis Acquires Four Generic Products From Akorn And Hi-Tech Pharmacal 32
InSite Vision Regains North American Development Rights To AzaSite Xtra From Inspire Pharma 33
Fresenius to Acquire Akorn 34
Akorn Acquires VersaPharm from Tailwind Capital Partners for USD433 Million 36
Valeant Pharma Acquires ECR Pharma from Akorn for USD41 Million 38
Akorn Completes Acquisition Of Hi-Tech Pharmacal For US$640 Million 39
Akorn Acquires Inspire Pharma From Merck For US$53 Million 40
Serum Institute Plans To Sell Its Stake In Akorn 42
Akorn To Acquire Minority Stake In Aciex Therapeutics 43
Merck Completes Acquisition Of Inspire Pharma 44
Metrics Acquires Midlothian Labs From Hi-Tech Pharmacal 46
Akorn Acquires Advanced Vision Research For US$26 Million 47
Akorn Inc, Key Competitors 48
Akorn Inc, Key Employees 49
Akorn Inc, Subsidiaries 50

List Of Figures

Akorn Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Akorn Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Akorn Inc, Medical Devices Deals, 2011 to YTD 2017 11

RELATED REPORTS

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

REVIEWS

There is no Reviews available

Search and Get the Latest Market Research Reports

Akorn Inc (AKRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Akorn Full Year Operating Financial

Akorn 2023 Third Quarter Operating and Financial Review

Akorn Inc (AKRX) - Financial and Strategic SWOT Analysis Review

FAQs